Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
1239 | 2767 | 27.1 | 63% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
7 | 4 | INFECTIOUS DISEASES//MICROBIOLOGY//VIROLOGY | 1353914 |
99 | 3 | HEPATITIS C VIRUS//HEPATITIS C//HEPATITIS B VIRUS | 74452 |
107 | 2 | HEPATITIS B VIRUS//HEPATITIS B//CHRONIC HEPATITIS B | 25371 |
1239 | 1 | HEPATITIS B VACCINE//HEPATITIS B//HEPATITIS B VACCINATION | 2767 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | HEPATITIS B VACCINE | authKW | 1507693 | 10% | 48% | 283 |
2 | HEPATITIS B | authKW | 690316 | 18% | 13% | 498 |
3 | HEPATITIS B VACCINATION | authKW | 588125 | 4% | 52% | 103 |
4 | ANTI HBS | authKW | 263664 | 2% | 44% | 54 |
5 | SEROPROTECTION | authKW | 138099 | 1% | 48% | 26 |
6 | RECOMBINANT HEPATITIS B VACCINE | authKW | 112835 | 1% | 68% | 15 |
7 | VACCINE | journal | 103323 | 15% | 2% | 411 |
8 | HBV VACCINATION | authKW | 100607 | 1% | 40% | 23 |
9 | VACCINATION | authKW | 100138 | 11% | 3% | 293 |
10 | ENGERIX B | authKW | 95358 | 0% | 79% | 11 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Infectious Diseases | 9350 | 18% | 0% | 492 |
2 | Immunology | 9096 | 28% | 0% | 784 |
3 | Medicine, Research & Experimental | 4979 | 17% | 0% | 460 |
4 | Medicine, General & Internal | 3481 | 18% | 0% | 485 |
5 | Public, Environmental & Occupational Health | 2974 | 14% | 0% | 400 |
6 | Gastroenterology & Hepatology | 2497 | 10% | 0% | 270 |
7 | Virology | 1423 | 6% | 0% | 164 |
8 | Tropical Medicine | 648 | 2% | 0% | 69 |
9 | Urology & Nephrology | 530 | 5% | 0% | 132 |
10 | Pediatrics | 404 | 5% | 0% | 143 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | EVALUAT VACCINAT | 40186 | 1% | 13% | 28 |
2 | INFECT DISSTATE DIAG TREATMENT | 33101 | 0% | 100% | 3 |
3 | VIROL DIS CONTROL | 33101 | 0% | 100% | 3 |
4 | ABT EPIDEMIOL INFEKTIONSKRANKHEITEN | 29421 | 0% | 67% | 4 |
5 | WHO ABORATING PREVENT CONTROL VIRAL HEP | 28447 | 0% | 37% | 7 |
6 | ITALIAN PREVENT LIVER DIS | 24824 | 0% | 75% | 3 |
7 | NEONATOL TER IA INTENS | 24824 | 0% | 75% | 3 |
8 | TRAVEL MED VACCINES | 24812 | 0% | 25% | 9 |
9 | VIRAL HEPATITIS | 24206 | 2% | 5% | 43 |
10 | AREA DIPARTIMENTALE EPIDEMIOL PREVENZ | 22067 | 0% | 100% | 2 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | VACCINE | 103323 | 15% | 2% | 411 |
2 | HUMAN VACCINES & IMMUNOTHERAPEUTICS | 14994 | 2% | 3% | 48 |
3 | HEPATITIS MONTHLY | 11543 | 1% | 4% | 29 |
4 | JOURNAL OF MEDICAL VIROLOGY | 8268 | 3% | 1% | 76 |
5 | DEVELOPMENTS IN BIOLOGICAL STANDARDIZATION | 5493 | 1% | 3% | 17 |
6 | JOURNAL OF INFECTION | 5248 | 2% | 1% | 43 |
7 | HUMAN VACCINES | 4682 | 1% | 3% | 15 |
8 | INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY | 2775 | 1% | 1% | 35 |
9 | PEDIATRIC INFECTIOUS DISEASE JOURNAL | 2771 | 2% | 1% | 49 |
10 | JOURNAL OF VIRAL HEPATITIS | 2379 | 1% | 1% | 22 |
Author Key Words |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | HEPATITIS B VACCINE | 1507693 | 10% | 48% | 283 | Search HEPATITIS+B+VACCINE | Search HEPATITIS+B+VACCINE |
2 | HEPATITIS B | 690316 | 18% | 13% | 498 | Search HEPATITIS+B | Search HEPATITIS+B |
3 | HEPATITIS B VACCINATION | 588125 | 4% | 52% | 103 | Search HEPATITIS+B+VACCINATION | Search HEPATITIS+B+VACCINATION |
4 | ANTI HBS | 263664 | 2% | 44% | 54 | Search ANTI+HBS | Search ANTI+HBS |
5 | SEROPROTECTION | 138099 | 1% | 48% | 26 | Search SEROPROTECTION | Search SEROPROTECTION |
6 | RECOMBINANT HEPATITIS B VACCINE | 112835 | 1% | 68% | 15 | Search RECOMBINANT+HEPATITIS+B+VACCINE | Search RECOMBINANT+HEPATITIS+B+VACCINE |
7 | HBV VACCINATION | 100607 | 1% | 40% | 23 | Search HBV+VACCINATION | Search HBV+VACCINATION |
8 | VACCINATION | 100138 | 11% | 3% | 293 | Search VACCINATION | Search VACCINATION |
9 | ENGERIX B | 95358 | 0% | 79% | 11 | Search ENGERIX+B | Search ENGERIX+B |
10 | HBV VACCINE | 84738 | 1% | 35% | 22 | Search HBV+VACCINE | Search HBV+VACCINE |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | KEATING, GM , NOBLE, S , (2003) RECOMBINANT HEPATITIS B VACCINE (ENGERIX-B (R)) - A REVIEW OF ITS IMMUNOGENICITY AND PROTECTIVE EFFICACY AGAINST HEPATITIS B.DRUGS. VOL. 63. ISSUE 10. P. 1021-1051 | 157 | 77% | 102 |
2 | LEURIDAN, E , VAN DAMME, P , (2011) HEPATITIS B AND THE NEED FOR A BOOSTER DOSE.CLINICAL INFECTIOUS DISEASES. VOL. 53. ISSUE 1. P. 68 -75 | 46 | 98% | 59 |
3 | FILIPPELLI, M , LIONETTI, E , GENNARO, A , LANZAFAME, A , ARRIGO, T , SALPIETRO, C , LA ROSA, M , LEONARDI, S , (2014) HEPATITIS B VACCINE BY INTRADERMAL ROUTE IN NON RESPONDER PATIENTS: AN UPDATE.WORLD JOURNAL OF GASTROENTEROLOGY. VOL. 20. ISSUE 30. P. 10383 -10394 | 74 | 61% | 10 |
4 | SCHONBERGER, K , RIEDEL, C , RUCKINGER, S , MANSMANN, U , JILG, W , VON KRIES, R , (2013) DETERMINANTS OF LONG-TERM PROTECTION AFTER HEPATITIS B VACCINATION IN INFANCY: A META-ANALYSIS.PEDIATRIC INFECTIOUS DISEASE JOURNAL. VOL. 32. ISSUE 4. P. 307-313 | 52 | 87% | 10 |
5 | POOROLAJAL, J , MAHMOODI, M , HAGHDOOST, A , MAJDZADEH, R , NASSERI-MOGHADDAM, S , GHALICHI, L , FOTOUHI, A , (2010) BOOSTER DOSE VACCINATION FOR PREVENTING HEPATITIS B.COCHRANE DATABASE OF SYSTEMATIC REVIEWS. VOL. . ISSUE 11. P. - | 54 | 90% | 6 |
6 | POOROLAJAL, J , MAHMOODI, M , HAGHDOOST, A , MAJDZADEH, R , NASSERI-MOGHADDAM, S , GHALICHI, L , FOTOUHI, A , (2010) BOOSTER DOSE VACCINATION FOR PREVENTING HEPATITIS B.COCHRANE DATABASE OF SYSTEMATIC REVIEWS. VOL. . ISSUE 12. P. - | 54 | 92% | 0 |
7 | WHITAKER, JA , ROUPHAEL, NG , EDUPUGANTI, S , LAI, LL , MULLIGAN, MJ , (2012) STRATEGIES TO INCREASE RESPONSIVENESS TO HEPATITIS B VACCINATION IN ADULTS WITH HIV-1.LANCET INFECTIOUS DISEASES. VOL. 12. ISSUE 12. P. 966-976 | 59 | 73% | 17 |
8 | ADKINS, JC , WAGSTAFF, AJ , (1998) RECOMBINANT HEPATITIS B VACCINE - A REVIEW OF ITS IMMUNOGENICITY AND PROTECTIVE EFFICACY AGAINST HEPATITIS B.BIODRUGS. VOL. 10. ISSUE 2. P. 137 -158 | 86 | 78% | 19 |
9 | KOMATSU, H , (2014) HEPATITIS B VIRUS: WHERE DO WE STAND AND WHAT IS THE NEXT STEP FOR ERADICATION?.WORLD JOURNAL OF GASTROENTEROLOGY. VOL. 20. ISSUE 27. P. 8998 -9016 | 74 | 49% | 15 |
10 | VITALITI, G , PRATICO, AD , CIMINO, C , DI DIO, G , LIONETTI, E , LA ROSA, M , LEONARDI, S , (2013) HEPATITIS B VACCINE IN CELIAC DISEASE: YESTERDAY, TODAY AND TOMORROW.WORLD JOURNAL OF GASTROENTEROLOGY. VOL. 19. ISSUE 6. P. 838-845 | 49 | 83% | 5 |
Classes with closest relation at Level 1 |